Hearing:
"The Role of Pharmacy Benefit Managers"
Subcommittee on the Administrative State, Regulatory Reform, and Antitrust (Committee on the Judiciary)
Wednesday, September 11, 2024 (2:00 PM)
2141 RHOB
Washington, D.C.
Witnesses
Dr. Richard Frank
Director, Health Program, Brookings Institution
Added
09/11/2024 at 04:56 PM
- Frank Testimony
[PDF]
Added
09/11/2024 at 04:56 PM
- Frank Truth in Testimony
[PDF]
Added
09/11/2024 at 04:56 PM
- Frank Bio
[PDF]
Added
09/11/2024 at 04:56 PM
Dr. Anthony T. LoSasso
Professor and Chair, Department of Economics, DePaul University
Added
09/11/2024 at 04:56 PM
- LoSasso Testimony
[PDF]
Added
09/11/2024 at 04:56 PM
- LoSasso Truth in Testimony
[PDF]
Added
09/11/2024 at 04:56 PM
- LoSasso Bio
[PDF]
Added
09/11/2024 at 04:56 PM
Dr. T. Joseph Mattingly II
Associate Professor and Vice Chair of Research, College of Pharmacy, University of Utah
Added
09/11/2024 at 04:56 PM
- Mattingly Testimony
[PDF]
Added
09/11/2024 at 04:56 PM
- Mattingly Truth in Testimony
[PDF]
Added
09/11/2024 at 04:56 PM
- Mattingly Bio
[PDF]
Added
09/11/2024 at 04:56 PM
Dr. Karen Van Nuys
Executive Director, Value of Life Sciences Innovation, USC Schaeffer Center
Added
09/11/2024 at 04:56 PM
- Van Nuys Testimony
[PDF]
Added
09/11/2024 at 04:56 PM
- Van Nuys Truth in Testimony
[PDF]
Added
09/11/2024 at 04:56 PM
- Van Nuys Bio
[PDF]
Added
09/11/2024 at 04:56 PM
Support Documents
- A report from Brookings titled, “A brief look at current debates about pharmacy benefit managers”, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/12/2024 at 11:01 AM
- A letter from California Life Sciences and California Pharmacists Association to members of the California Congressional Delegation regarding PBM reforms, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/12/2024 at 11:01 AM
- A report from Compass Lexecon titled, “PBMs and Prescription Drug Distribution: An Economic Analysis of Criticisms Levied Against Pharmacy Benefit Managers”, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/12/2024 at 11:01 AM
- A report from Drug Channels Institute titled, “The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers”, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/12/2024 at 11:01 AM
- An article from The New York Times titled, “The Opaque Industry Secretly Inflating Prices for Prescription Drugs”, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/12/2024 at 11:01 AM
- A report from the Federal Trade Commission titled, “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies”, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/12/2024 at 11:01 AM
- A letter dated June 5, 2024, from PhRMA to Assistant Attorney General Kanter, Secretary Becerra, and Chair Khan regarding the consolidation of the health care market, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/12/2024 at 11:01 AM
- An article from the Wall Street Journal titled, “Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.”, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/12/2024 at 11:01 AM
- A statement of dissent dated July 9, 2024, from Commissioner Melissa Holyoak of the Federal Trade Commission in the matter of the Pharmacy Benefit Managers Report, submitted for the Record by Mr. Moran of TX
[PDF]
Added
09/12/2024 at 11:01 AM
Hearing Record
- A question for the record to all witnesses, submitted for the Record by Mr. Correa of CA
[PDF]
Added
09/20/2024 at 12:14 PM
- Response to the question for the record from Dr. Mattingly
[PDF]
Added
09/23/2024 at 09:13 AM
- Response to the question for the record from Dr. Van Nuys
[PDF]
Added
10/01/2024 at 03:27 PM
- Response to the question for the record from Dr. LoSasso
[PDF]
Added
10/02/2024 at 02:14 PM
- Response to the question for the record from Dr. Frank
[PDF]
Added
10/03/2024 at 01:40 PM
First Published:
September 4, 2024 at 04:29 PM
Last Updated:
October 3, 2024 at 01:40 PM